Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non–Small Cell Lung Cancer

Published:2018-04 Issue:4 Volume:13 Page:550-558
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hubbeling Harper G.^ORCID,Schapira Emily F.,Horick Nora K.,Goodwin Kelly E.H.,Lin Jessica J.,Oh Kevin S.,Shaw Alice T.,Mehan William A.,Shih Helen A.,Gainor Justin F.

Funder

Treatment Center Clinical Trials Umbrella

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Epidemiology of brain metastases;Nayak;Curr Oncol Rep,2012

2. Systematic review of brain metastases in patients with non-small-cell lung cancer in the United States, European Union, and Japan;Fenske;Clin Lung Cancer,2017

3. Pembrolizumab versus chemotherapy for PD-L1 positive non small cell lung cancer;Reck;N Engl J Med,2016

4. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer;Carbone;N Engl J Med,2017

5. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

2. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;Clinical Lung Cancer;2024-09

3. CBNPC sans addictions oncogéniques métastatique cérébral d’emblée : place de l’immunothérapie;Revue des Maladies Respiratoires;2024-06

4. Radiotherapy enhances efficacy of PD-1 inhibitors in advanced hepatocellular carcinoma: A propensity-matched real-world study;Chinese Medical Journal;2024-05-09

5. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy;Frontiers in Immunology;2024-01-12